![Torben Arnth Nielsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Torben Arnth Nielsen
Vorstandsvorsitzender bei
Arnth Advice ApS
Profil
Torben Arnth Nielsen is currently the Chairman at BI Biomedical Venture Annex Komplementar A, Director at Bioporto Diagnostics A, Managing Director & Director at Arnth Advice ApS, and Director at Wavepiston A. Previously, he served as the Chief Executive Officer at BI Asset Management Fondsmæglerselskab A, Chief Executive Officer at BankInvest AS from 2008 to 2012, Vice Chairman at Bioporto A from 2013 to 2021, Director at Nasdaq Copenhagen A, Director at Veterinary Diagnostics Institute, Inc., and Member-Executive Board at Sydbank A from 1998 to 2008.
Aktive Positionen von Torben Arnth Nielsen
| Unternehmen | Position | Beginn |
|---|---|---|
BI Biomedical Venture Annex Komplementar A/S
 BI Biomedical Venture Annex Komplementar A/S Financial ConglomeratesFinance Provides financial services | Vorsitzender | 04.02.2011 |
Arnth Advice ApS | Vorstandsvorsitzender | - |
Wavepiston A/S
 Wavepiston A/S Electric UtilitiesUtilities Develops and delivers wave energy technology for power production and desalination | Direktor/Vorstandsmitglied | - |
Bioporto Diagnostics A/S
 Bioporto Diagnostics A/S BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Torben Arnth Nielsen
| Unternehmen | Position | Ende |
|---|---|---|
| BIOPORTO A/S | Direktor/Vorstandsmitglied | 29.04.2021 |
BankInvest AS
 BankInvest AS Financial ConglomeratesFinance Provides investment services | Vorstandsvorsitzender | 01.01.2012 |
BI Asset Management Fondsmæglerselskab A/S
 BI Asset Management Fondsmæglerselskab A/S Investment ManagersFinance BIAM emphasizes long-term investments, bottom-up stock-picking approach and cash flow analysis. They base their investment process on fundamental research including company visits and extensive use of outsourced industrial expertise from non-financial analysts associated with the sectors in which they invest. The firm invests globally in listed equity, debt and alternative asset classes including private equity. BIAM favors companies with strong cash flow, growth potential within their sector and solid business models. They have specialist expertise in emerging market securities, both equity and fixed income, and invest in the Far East, Latin America and Eastern Europe. | Präsident | 08.09.2011 |
| AL SYDBANK A/S | Corporate Officer/Principal | 01.01.2008 |
Nasdaq Copenhagen A/S
 Nasdaq Copenhagen A/S Investment Banks/BrokersFinance Engages in financial market and trading services | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
44
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Nasdaq Copenhagen A/S
Nasdaq Copenhagen A/S Investment Banks/BrokersFinance Engages in financial market and trading services | Finance |
BI Asset Management Fondsmæglerselskab A/S
BI Asset Management Fondsmæglerselskab A/S Investment ManagersFinance BIAM emphasizes long-term investments, bottom-up stock-picking approach and cash flow analysis. They base their investment process on fundamental research including company visits and extensive use of outsourced industrial expertise from non-financial analysts associated with the sectors in which they invest. The firm invests globally in listed equity, debt and alternative asset classes including private equity. BIAM favors companies with strong cash flow, growth potential within their sector and solid business models. They have specialist expertise in emerging market securities, both equity and fixed income, and invest in the Far East, Latin America and Eastern Europe. | Finance |
Sydbank A/S
 Sydbank A/S Major BanksFinance Provides commercial banking and asset management services | Finance |
Bioporto A/S
 Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
BI Biomedical Venture Annex Komplementar A/S
BI Biomedical Venture Annex Komplementar A/S Financial ConglomeratesFinance Provides financial services | Finance |
Bioporto Diagnostics A/S
Bioporto Diagnostics A/S BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Veterinary Diagnostics Institute, Inc.
 Veterinary Diagnostics Institute, Inc. Medical/Nursing ServicesHealth Services Provides veterinary reference laboratory services and in-house diagnostic products | Health Services |
Arnth Advice ApS | |
Wavepiston A/S
Wavepiston A/S Electric UtilitiesUtilities Develops and delivers wave energy technology for power production and desalination | Utilities |
BankInvest AS
BankInvest AS Financial ConglomeratesFinance Provides investment services | Finance |
